Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer.
Betella I, Turbitt WJ, Szul T, Wu B, Martinez A, Katre A, Wall JA, Norian L, Birrer MJ, Arend R. Wnt signaling modulator DKK1 as an immunotherapeutic target in ovarian cancer. Gynecol Oncol. 2020 06; 157(3):765-774.